TITLE

RESEARCH. The cluster-randomized Quality Initiative in Rectal Cancer trial: evaluating a quality-improvement strategy in surgery

AUTHOR(S)
Simunovic, Marko; Coates, Angela; Goldsmith, Charles H.; Thabane, Lehana; Reeson, Dana; Smith, Andrew; McLeod, Robin S.; DeNardi, Franco; Whelan, Timothy J.; Levine, Mark N.
PUB. DATE
September 2010
SOURCE
CMAJ: Canadian Medical Association Journal;9/7/2010, Vol. 182 Issue 12, p1301
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Following surgery for rectal cancer, two unfortunate outcomes for patients are permanent colostomy and local recurrence of cancer. We tested whether a quality-improvement strategy to change surgical practice would improve these outcomes. Methods: Sixteen hospitals were cluster-randomized to the intervention (Quality Initiative in Rectal Cancer strategy) or control (normal practice) arm. Consecutive patients with primary rectal cancer were accrued from May 2002 to December 2004. Surgeons at hospitals in the intervention arm could voluntarily participate by attending workshops, using opinion leaders, inviting a study team surgeon to demonstrate optimal techniques of total mesorectal excision, completing postoperative questionnaires, and receiving audits and feedback. Main outcome measures were hospital rates of permanent colostomy and local recurrence of cancer. Results: A total of 56 surgeons (n = 558 patients) participated in the intervention arm and 49 surgeons (n = 457 patients) in the control arm. The median follow-up of patients was 3.6 years. In the intervention arm, 70% of surgeons participated in workshops, 70% in intraoperative demonstrations and 71% in postoperative questionnaires. Surgeons who had an intraoperative demonstration provided care to 86% of the patients in the intervention arm. The rates of permanent colostomy were 39% in the intervention arm and 41% in the control arm (odds ratio [OR] 0.97, 95% confidence interval [CI] 0.63-1.48). The rates of local recurrence were 7% in the intervention arm and 6% in the control arm (OR 1.06, 95% CI 0.68-1.64). Interpretation: Despite good participation by surgeons, the resource-intense quality-improvement strategy did not reduce hospital rates of permanent colostomy or local recurrence compared with usual practice. (ClinicalTrials.gov trial register no. NCT00182130.)
ACCESSION #
54106386

 

Related Articles

  • Local recurrence following rectal resection for cancer. Eu, K.-W.; Seow-Choen, F.; Ho, J.M.S.; Ho, Y.H.; Leong, A.F.P.K. // Journal of the Royal College of Surgeons of Edinburgh;Dec98, Vol. 43 Issue 6, p393 

    Examines departmental results following rectal cancer surgery to determine local recurrence rates. Poor prognosis in recurrent rectal carcinoma following surgery; Incidence of local recurrence; Suggested treatment of rectal cancer by surgeons with special interest and training.

  • An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation. Cascinu, S.; Graziano, F.; Catalano, V.; Staccioli, M.P.; Rossi, M.C.; Baldelli, A.M.; Barni, S.; Brenna, A.; Secondino, S.; Muretto, P.; Catalano, G. // British Journal of Cancer;3/4/2002, Vol. 86 Issue 5, p744 

    Tumours of patients with node-positive rectal cancer were studied by immunohistochemistry for p53. BAX and vascular endothelial growth factor expressions. Results were correlated to the relapse rate, the pattern of relapse and the event free survival after radical surgery and adjuvant...

  • Retrospective review of rectal cancer surgery in northern Alberta. Pelletier, Jean-S├ębastien; DeGara, Christopher; Porter, Geoff; Ghosh, Sunita; Schiller, Dan // Canadian Journal of Surgery;Aug2013, Vol. 56 Issue 4, pE51 

    Introduction: Previous studies, including research published more than 10 years ago in Northern Alberta, have demonstrated improved outcomes with increased surgical volume and subspecialisation in the treatment of rectal cancer. We sought to examine contemporary rectal cancer care in the same...

  • Results of treatment of distal rectal carcinoma since the introduction of total mesorectal excision: a single unit experience, 1994-2003. Chiappa, Antonio; Biffi, Roberto; Zbar, Andrew P.; Luca, Fabrizio; Crotti, Cristiano; Bertani, Emilio; Biella, Francesca; Zampino, Giulia; Orecchia, Roberto; Fazio, Nicola; Venturino, Marco; Crosta, Cristiano; Pruneri, Gian Carlo; Grassi, Carmine; Andreoni, Bruno // International Journal of Colorectal Disease;May2005, Vol. 20 Issue 3, p221 

    Background and aims: This study reviewed the results of surgery for distal rectal cancer (where the tumour was within 6 cm of the anal verge) following the introduction of total mesorectal excision for rectal cancer in one institution. Patients and methods: One hundred and fifty-three patients...

  • Surgery for recurrent rectal cancer: technical notes and management of complications. Mirnezami, A. H.; Sagar, P. M. // Techniques in Coloproctology;Sep2010, Vol. 14 Issue 3, p209 

    Local recurrence following surgery for rectal cancer remains a significant clinical problem and poses major therapeutic challenges. Radical surgical salvage is the only option with potential for curative treatment and is indicated in carefully selected patients. Surgery also provides acceptable...

  • Loco-regional relapses from rectal cancer. Izzo, L.; Pietrasanta, D.; Trombetta, S.; Bolognese, A. // BMC Geriatrics;2009 Supplement 1, Vol. 9, p1 

    Background Loco-regional relapses (LRRs) from rectal cancer still represent a major issue in colo-rectal surgery. With the introduction of Total Mesorectal Excision (TME), LRR incidence after curative resection for rectal cancer dramatically decreased from 20-40% of cases to 2-12%. Several...

  • Early distant relapse after optimal local control in locally advanced rectal cancer. Gallego-Plazas, Javier; Menarguez-Pina, Francisco; Martinez-Banaclocha, Natividad; Pons-Sanz, Vanesa; Mingol-Navarro, Fernando; Ruiz-Macia, Jose A.; Macia-Escalante, Sonia // International Seminars in Surgical Oncology;2008, Vol. 5, Special section p1 

    We present a case of locally advanced rectal cancer with initial optimal local control after neoadjuvant concurrent chemoradiotherapy followed by surgery; early liver recurrence then occurred and was treated again with curative intent with neoadjuvant combination chemotherapy followed by liver...

  • The Quality Initiative in Rectal Cancer (QIRC) trial: study protocol of a cluster randomized controlled trial in surgery. Simunovic, Marko; Goldsmith, Charles; Thabane, Lehana; McLeod, Robin; DeNardi, Franco; Whelan, Timothy J.; Levine, Mark N. // BMC Surgery;2008, Vol. 8, Special section p1 

    Background: Two unfortunate outcomes for patients treated surgically for rectal cancer are placement of a permanent colostomy and local tumor recurrence. Total mesorectal excision is a new technique for rectal cancer surgery that can lead to improved patient outcomes. We describe a cluster...

  • Radical redo surgery for local rectal cancer recurrence improves overall survival: a single center experience. Schurr, Paulus; Lentz, Edda; Block, Suzette; Kaifi, Jussuf; Kleinhans, Helge; Cataldegirmen, Guellue; Kutup, Asad; Schneider, Claus; Strate, Tim; Yekebas, Emre; Izbicki, Jakob // Journal of Gastrointestinal Surgery;Jul2008, Vol. 12 Issue 7, p1232 

    Background: To date, the survival benefit of redo surgery in locally recurrent rectal adenocarcinoma remains unclear.Study Design: In an institutional study, operations for recurrence were retrospectively analyzed. Survival was calculated using the Kaplan-Meier plot and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics